Viatris Inc (VTRS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
$8.92
Buy
$9.01
$0.19 (+2.17%)
Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.
Prices updated at 13 May 2025, 00:25 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Robert J. Coury
CEO
Mr. Scott A. Smith
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
32,000
Head office
1000 Mylan Boulevard
Canonsburg
United States
15317
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Harry A. Korman Independent Director | 0.18m | - | - | 0.38m | - |
Mr. Rajiv Malik Director | 1.30m | - | - | 12.48m | - |
Dr. Michael Severino, M.D. Independent Director | - | - | - | - | - |
Mr. Frank D’Amelio Independent Director | - | - | - | - | - |
Ms. Elisha W. Finney Independent Director | 0.15m | - | - | 0.37m | - |
Mr. James M. Kilts Independent Director | 0.15m | - | - | 0.37m | - |
Mr. Wyllie Don Cornwell Independent Director | 0.15m | - | - | 0.37m | - |
Mr. Mark W. Parrish Vice Chairman of the Board | 0.25m | - | - | 0.45m | - |
Mr. Scott A. Smith Director and Chief Executive Officer | 1.02m | - | - | 15.93m | - |
Ms. Melina E. Higgins Chairman of the Board | 0.23m | - | - | 0.45m | - |
Ms. JoEllen Lyons Dillon Independent Director | 0.20m | - | - | 0.40m | - |
Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. Independent Director | - | - | - | - | - |
Mr. Paul B. Campbell Chief Accounting Officer and and Corporate Controller | - | - | - | - | - |
Mr. Richard A. Mark, C.P.A. Independent Director | 0.20m | - | - | 0.42m | - |
Mr. Leo Groothuis Independent Director | 0.11m | - | - | 0.31m | - |
Ms. Theodora Mistras Chief Financial Officer | - | - | - | - | - |
Mr. Robert J. Coury Chairman Emeritus | 1.91m | - | - | 41.50m | - |
Dr. Corinne Le Goff, Pharm.D. Chief Commercial Officer | - | - | - | - | - |
Mr. Brian Roman Chief Legal Officer | 0.79m | - | - | 4.11m | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 142,131,112 | 0.03082 | 1105396 | 0.783826 | 30 Apr 2025 | 11.99 |
| BlackRock Inc | 94,132,007 | 0.02371 | 101930 | 0.108401 | 30 Apr 2025 | 7.94 |
| State Street Corp | 63,749,447 | 0.03131 | 633514 | 1.003731 | 30 Apr 2025 | 5.38 |
| Davis Selected Advisers | 62,573,562 | 4.52763 | -73704 | -0.117649 | 30 Apr 2025 | 5.28 |
| Davis Selected Advisers LP | 62,647,266 | - | -14462 | -0.023079 | 30 Apr 2025 | 5.25 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 11 Nov 2024 | - | Mr. Paul B. Campbell | 12.88 | 346,686 | 126,901 | - | - |
| 12 Sep 2024 | - | Mr. Rajiv Malik | 11.71 | 706,553 | - | - | - |
| 12 Sep 2024 | - | Mr. Rajiv Malik | 11.66 | 1,628,164 | 505,838 | - | - |
| 30 Aug 2024 | - | Mr. Rajiv Malik | 12.00 | 600,000 | 60,319 | - | - |
| 28 Aug 2024 | - | Mr. Rajiv Malik | 11.90 | 595,075 | 110,319 | - | - |
| 22 Aug 2024 | - | Mr. Rajiv Malik | 11.73 | 1,172,630 | 260,319 | - | - |
| 21 Aug 2024 | - | Mr. Rajiv Malik | 11.75 | 1,175,260 | 360,319 | - | - |
| 23 Aug 2024 | - | Mr. Rajiv Malik | 11.75 | 1,175,100 | 160,319 | - | - |
| 13 Jun 2024 | - | Mr. Rajiv Malik | 10.52 | 900,741 | 909,819 | - | - |
| 14 Jun 2024 | - | Mr. Rajiv Malik | 10.18 | 2,690,283 | 645,519 | - | - |
| 03 Jun 2024 | - | Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | - | - | 21,267 | - | - |
| 28 May 2024 | - | Mr. Brian Roman | 10.38 | 928,429 | 67,723 | - | - |
| 18 Apr 2024 | - | Dr. Corinne Le Goff, Pharm.D. | - | - | 78,688 | - | - |
| 18 Apr 2024 | - | Dr. Corinne Le Goff, Pharm.D. | - | - | 110,162 | - | - |
| 02 Apr 2024 | - | Mr. Rajiv Malik | - | - | 18,845 | - | - |
| 13 Mar 2024 | - | Mr. Anthony Mauro | 12.09 | 3,023,700 | 243,044 | - | - |
| 04 Mar 2024 | - | Ms. Theodora Mistras | - | - | 93,447 | - | - |
| 04 Mar 2024 | - | Ms. Elisha W. Finney | - | - | 18,204 | - | - |
| 03 Mar 2024 | - | Ms. Elisha W. Finney | - | - | - | - | - |
| 03 Mar 2024 | - | Ms. Elisha W. Finney | - | - | - | - | - |
Please note that past performance is not a reliable indicator of future returns.
